News | April 21, 2014

Prostate Carcinoma Is the Most Frequent Diagnosis Treated at Proton Therapy Center Czech

The center in Prague offers noninvasive, outpatient treatment with 97 percent curability

Prostate Cancer Czech Proton Therapy Center Diagnosis Treatment

April 21, 2014 — Proton Therapy Center Czech is located in the capital of the Czech Republic and has successfully entered its second year of operation. Since the beginning, it has made itself available to patients from all over the world has to date has treated patients from 18 different countries — including Great Britain, France, Belgium, Germany, Norway, Switzerland and the Russian federation. The mix of clinical indications corresponds with world trends — half of the patients treated were with prostate cancer. For them proton therapy offers a new revolutionary chance for a smooth recovery and a rapid return to their usual daily lives following treatment.

Thus far, oncology patients have undergone proton therapy with no complications and the detailed examinations given after treatment only confirm that their health improving and they have great perspectives on their future quality of life without undesirable treatment-related side effects — that are often associated with the conventional radiation methods.

Proton Therapy Center Czech in Prague utilizes the most advanced form of proton therapy scanning available today — in the form of what is simply referred to as pencil beam scanning. This remarkable tool enables tumor treatment with millimeter precision, without damaging to surrounding healthy structures. Additionally all diagnostic methods including positron emission tomography/computed tomography (PET/CT) are available in a single, centralized location. Therefore examinations and planning times are shortened by up to 14 days. It is well established fact that surgery and conventional radiotherapy using photons (X-rays), can cause serious long-term side effects such as erectile dysfunction, loss of fertility, as well as various forms of urinary incontinence, rectal inflammation and bleeding, and intestinal fibrosis. While conventional X-ray radiation unnecessarily exposes up to 50 percent more health tissue to unwanted radiation, protons on the other hand can be precisely focused only upon the tumor without damaging sensitive health organs and tissues around it. Last but not least, the majority of patients are able to maintain their sexual potency.

Ji?í Kubeš, Ph.D., Head of Proton Therapy at Proton Therapy Center Czech said, “Proton radiotherapy offers the highest chance for maintaining sexual potency after treatment. The percentage of those who suffer from incontinence is much smaller than after surgery. A very low dose of radiation decreases the risk of damage to intestines. From our treatment experience thus far, the acute complications regress 14 days following the end of treatment. This means that none of our patients were forced to limit his or her life and work activities during treatment. Patients have not needed to go on sick leave at all during their treatment.“

The excellent results of treatment of prostate can be demonstrated by the new report from Washington by National Association for Proton Therapy.

For more information: www.proton-therapy.org

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...